Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Lexicon Pharmaceutcl (LXRX)

Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ivan H. Cheung Elected to Board of Directors of Lexicon Pharmaceuticals, Inc. Quiver Quantitative, Inc. - Thu Nov 21, 1:20AM CST

Lexicon Pharmaceuticals announces Ivan H. Cheung’s election to its Board of Directors, highlighting his extensive biopharmaceutical experience.Quiver AI SummaryLexicon Pharmaceuticals, Inc. has announced...

LXRX : 0.8005 (-0.85%)
Lexicon Appoints Ivan H. Cheung to Board of Directors GlobeNewswire - Wed Nov 20, 3:05PM CST

LXRX : 0.8005 (-0.85%)
Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations is Among Four Lexicon-Supported Presentations at the American Heart Association’s (AHA) Sessions 2024 in Chicago GlobeNewswire - Thu Nov 14, 7:00AM CST

LXRX : 0.8005 (-0.85%)
Lexicon: Q3 Earnings Snapshot AP - Tue Nov 12, 3:25PM CST

Lexicon: Q3 Earnings Snapshot

LXRX : 0.8005 (-0.85%)
Lexicon Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Tue Nov 12, 3:05PM CST

LXRX : 0.8005 (-0.85%)
Lexicon Pharmaceuticals to Participate in the Jefferies London Global Healthcare Conference GlobeNewswire - Wed Nov 6, 7:00AM CST

LXRX : 0.8005 (-0.85%)
Published Data in Journal of American Society of Nephrology Highlights Findings on Efficacy and Safety of Sotagliflozin for People With Type 1 Diabetes and Chronic Kidney Disease GlobeNewswire - Tue Nov 5, 3:05PM CST

LXRX : 0.8005 (-0.85%)
Lexicon Pharmaceuticals to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 12, 2024 GlobeNewswire - Tue Nov 5, 7:00AM CST

LXRX : 0.8005 (-0.85%)
Lexicon to Present Preclinical IN VIVO Efficacy Data Demonstrating Ability of New Investigational Compound to Enhance and Maintain Semaglutide-Promoted Weight Loss GlobeNewswire - Mon Nov 4, 7:00AM CST

LXRX : 0.8005 (-0.85%)
Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease GlobeNewswire - Thu Oct 31, 5:54PM CDT

LXRX : 0.8005 (-0.85%)

Barchart Exclusives

ELF’s Unusual Options Activity Is a Thing of Questionable Beauty Barchart - 32 minutes ago
E.L.F. Beauty’s options volume on Wednesday was 7x the 30-day average. The affordable makeup and skincare company’s unusual options activity stood out as one investor questioned its revenues. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot